Friday, September 18

Friday, September 18, 2026

Everything we published on this day.

62 stories — the front page that day →

@AsifSuria

Asif Suria on X

Yes these Celsius $CELH purchases certainly stood out when we were looking at insider buys this week. They were also buying at similar prices in May. Although those Nov 2025 purchases by the same director that was buying this week (Hal Kravitz) and by their COO were not timed well. Kravitz was previously a Coca Cola executive and has been on Celsius' board for over 10 years. We usually like to see opportunistic insider purchases by independent directors with long tenure on the board.

The Week That Was

Federal Reserve’s quarter-point hike failed to contain 10-year yields above 5%, while rising legacy-chip rentals and AI safety compute…

Groceries, Aggregators, and Agents

DoorDash's grocery push targets a shift from weekly stock-up trips to frequent online fill-in orders, though smaller baskets complicate…

@BrokenMoats 1 click

Broken Moats on X

Could see $JACK, $WEN, $PZZA all go bankrupt. Probably others across the QSR space (subway, Pizza Hut some of the more challenged private operators) -- to be fair some of these could get acquired too but interesting how that would play through commercial real estate and impact the non distressed survivors -- very challenging space with prices having soared (affordability) and consumers pushing back or finding better/comparable value at a Chili's etc. Freight costs (diesel and trucker shortage from policy moves) and food costs that are/will escalate (freight and commodities) is going to bring new challenges to margins. Menu prices likely need to reset lower across many of these chains but that is a very difficult process for owners and franchises to accomplish especially while input costs continue to rise. GLP1s hurt overall volume trends as well but......look out to automation/robotics in store and how trends tend to switch back to QSR/fast food in a more stressed economic condition there might be select opportunities in the coming months for a few players as prices have/are resetting fast across tis space
@KEDM_COM 2 clicks

KEDM.com on X

Right Tail @JeremyKokemor bought $HCA at about 12x earnings on a local-density argument: hospitals compete neighborhood by neighborhood, and HCA holds #1 or #2 share — averaging 25-30% of each market in about 80% of its markets, primarily in Sunbelt states. Outpatient access points — 14 per hospital, heading toward 20 — feed the hospitals, and about 75% of admissions arrive through the ER. Margins held in the high teens through 2009, and half the shares have been retired since the 2011 re-IPO. Historically, HCA has compounded revenue at roughly 7% annually and EPS closer to 17%; Right Tail models mid-single-digit revenue growth and 10-15% EPS growth.

TSOH Weekly Roundup (09/18/2026)

TSOH Weekly Roundup covers organized retail crime, Home Depot’s centralized operating missteps under Bob Nardelli, and research updates on…

QNT: The 100× Question

Quantinuum's improving logical-qubit error correction, 1,504 successful-circuit benchmark score and paid deployments at RIKEN, BMW and…

@Fierce__beast 2 clicks

Fierce_beast on X

Here's the J-curve stock shape -- many examples of software stocks and high growth stocks, sometimes even large mature companies that release a new product. $MPWR was shaping up for this in November 2024 (I wrote about this and went long) when it dropped a lot after they "lost $NVDA" marketshare, but of course their custom AI accelerator business was growing something like 100% a year, and it was only a matter of time before it showed up in the earnings. It subsequently re-rated after troughing at 35x and had significant earnings growth. Today it goes for 35x again. Will there be another big bump in a few years, maybe robotics?
@Fierce__beast 1 click

Fierce_beast on X

This is the shape of many AI related beneficiaries that I think is the most likely path, a few bumps along the way of course, but more or less the path: $AVGO is an interesting example it has expected EPS growth that looks almost exactly like this, but it doesn't trade for 67.5x, it trades for 20x, which seems to imply that earnings growth rate expectations will pretty dramatically slow down within the next 12-24 months. This doesn't seem likely to me. Of course when I say expected EPS these views are extrapolations of near-term trends and discussions about long-term demand, but all i am making a point about is that if $AVGO's estimates actually materialize roughly like the consensus estimates think, the stock should probably be at least 100% higher.

Deep Dive: Grab Holdings ($GRAB)

Grab generates 53% of revenue from delivery, 36% from mobility and 10% from financial services, using its Southeast Asian marketplace to…

@Fierce__beast

Fierce_beast on X

Comedian talking sense about $JMKE. Just like how Wendy's went to shredded lettuce instead of Iceburg, $JMKE sandwich quality started deteriorating 2 years ago according to this guy. Not counting them out, but not looking great. I made this mistake of buying $JOAN after it IPO'd. Amazing growth, amazing margins, 12x P/E! Of course it was being undermaintained and quality quickly deteriorated post-covid. Beware of private equity and short-term oriented management teams.
@Fierce__beast

Fierce_beast on X

$INMD has 8.5/sh of cash, a 14.5/sh stock price, and around my estimate of .7/sh of eps after accounting for capital requirements and excluding interest income. If this is right, that means it's trading around 8x p/e (6/.7) for just the operating business. Even if you thought it should only be 4x p/e (3/.7), that's 3$ of downside (20%) on a 14.5/sh stock. Vice versa, if you thought it should be 12x p/e (8.4/.7), that's 2.4$ of upside (16%) on a 14.5/sh stock. Suppose a rational stock market investor requires a 9% return, and if he valued a stock at 8x p/e, that multiple would be consistent with a perpetual earnings decline around 3% annually. For a 4x p/e that rate would be closer to 13%. Should we value INMD's future cash stream at an 8x NTM P/E, above, or below? INMD's earnings seems to be declining much faster than 3% annually, even faster than 11% annually. There seems to be a lot of competition, a lot of issues with their strategy, constnat negative revisions, constant missed promises and dissapointments. Wonder what's going on underneath